The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.

Autor: Kingsley, Jeff1 (AUTHOR), Kumarasamy, Nagalingeswaran2 (AUTHOR), Abrishamian, Luis3 (AUTHOR), Bonten, Marc4 (AUTHOR), Igbinadolor, Awawu5 (AUTHOR), Mekebeb-Reuter, Martha6 (AUTHOR), Rosa, Jennifer7 (AUTHOR), Elango, Damodaran Solai8 (AUTHOR), Lopez, Patricia9 (AUTHOR), Fustier, Pierre10 (AUTHOR), Goncalves, Susana9 (AUTHOR), Knutson, Charles G11 (AUTHOR), Kukkaro, Petra9 (AUTHOR), Legenne, Philippe10 (AUTHOR), Ramanathan, Krishnan9 (AUTHOR), Rao, Shantha12 (AUTHOR), Reshetnyak, Evgeniya12 (AUTHOR), Stavropoulou, Vaia10 (AUTHOR), Stojcheva, Nina10 (AUTHOR), Stumpp, Michael T10 (AUTHOR)
Zdroj: Open Forum Infectious Diseases. Jun2024, Vol. 11 Issue 6, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje